Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Colorectal cancer risk elevated in anticoagulated AF patients with lower GI bleeding

Key clinical point: Patients with atrial fibrillation who are treated with oral anticoagulants and then suffer from lower GI bleeding have a higher risk of colorectal cancer.

Major finding: ll age groups had a higher risk of colorectal cancer after lower GI bleeding, compared with patients without bleeding, especially patients aged 65 or younger (risk ratio, 24.2 95% confidence interval, 14.5-40.4).

Study details: A nationwide retrospective study of 125,418 Danish patients with AF.

Disclosures: Two of the authors are employees at Bristol-Myers Squibb and Pfizer, respectively. Six additional authors reported receiving grants, speaker honoraria and consulting fees from various pharmaceutical companies. The remaining authors reported no conflicts of interest.

Citation:

Rasmussen PV et al. Eur Heart J. 2020 Feb 7. doi: 10.1093/eurheartj/ehz964.